Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: BYl719
Sponsor: Peter MacCallum Cancer Centre, Australia
Collaborators: Novartis Pharmaceuticals